Use of Risankizumab in Severe Asthma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial
N. Engl. J. Med 2021 Oct 28;385(18)1669-1679, CE Brightling, P Nair, DJ Cousins, R Louis, D SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.